KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Amneal Pharmaceuticals (AMRX) Shares Outstanding (Weighted Average) (2017 - 2026)

Amneal Pharmaceuticals has reported Shares Outstanding (Weighted Average) over the past 9 years, most recently at $313.4 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 1.42% year-over-year to $313.4 million; the TTM value through Dec 2025 reached $313.4 million, up 1.42%, while the annual FY2025 figure was $313.4 million, 1.42% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $313.4 million at Amneal Pharmaceuticals, roughly flat from $314.2 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $314.2 million in Q3 2025 and troughed at $148.0 million in Q1 2021.
  • A 5-year average of $219.4 million and a median of $153.7 million in 2023 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): increased 0.57% in 2021 and later skyrocketed 102.01% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $149.3 million in 2021, then grew by 1.11% to $150.9 million in 2022, then increased by 16.69% to $176.1 million in 2023, then skyrocketed by 75.42% to $309.0 million in 2024, then grew by 1.42% to $313.4 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for AMRX at $313.4 million in Q4 2025, $314.2 million in Q3 2025, and $312.4 million in Q2 2025.